AGI Therapeutics Plc - AGI to Present at DDW
                   
redorbit.com     May 15, 2008          

5 p.m., Tuesday 20 May, 2008 -- AGI Therapeutics plc ("AGI" or the "Company") (AIM, IEX: AGI), a speciality pharmaceutical company focused on gastrointestinal drug products, today announces it will present three poster presentations at Digestive Disease Week (DDW) at the San Diego Convention... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Featured Persons

View other selected articles:

HEALTH CANADA STOPPED SALE OF PREXIGE IN CANADA

mediconews.com     3 hrs ago          

Osteoarthritis :: Health Canada obstructed understanding of Prexige in Canada Health Canada is advising consumers that it has obstructed the understanding of the anti-inflammatory take Prexige (lumiracoxib) in Canada and module...                

comments

Generic Heartburn at Wyeth (at Motley Fool)

yahoo.com     yesterday          

By Brian Orelli July 25, 2008 Comments (0) Wyeth (NYSE: WYE) has a serious case of generic-induced heartburn that's not likely to go away any time soon. Revenue from its heartburn drug Protonix dropped 59% year over year after...                

comments

Defining In Vivo Mucosal Inflammatory Activity Using Laser Scanning Confocal Endomicroscopy in...

biowizard.com     yesterday          

Gastroenterology and Liver Unit at the Royal Hallamshire Hospital, Sheffield, England. BACKGROUND & AIMS: Colonoscopy with mucosal biopsy is currently considered the criterion standard for the assessment of disease activity and...                

comments

                   

Global Probiotics Council Announces First Awardees for New Young Investigator Grant for...

prnewswire.com     Jul 24, 2008          

Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research ALEXANDRIA, Va., July 24 /PRNewswire/ -- The Global Probiotics Council (GPC), a committee established in 2004 by Groupe...                

comments